NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球頭頸部癌症市場:診斷成像設備,內視鏡篩檢設備,切片檢查篩檢檢驗,牙科診斷法,各地區 - 成長,趨勢,預測(2018年∼2023年)

Head and Neck Cancer Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 390801
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
全球頭頸部癌症市場:診斷成像設備,內視鏡篩檢設備,切片檢查篩檢檢驗,牙科診斷法,各地區 - 成長,趨勢,預測(2018年∼2023年) Head and Neck Cancer Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

頭頸部癌症,是全球最常見的癌症之一,尤其是飲酒、抽煙多的地區顯著。全球頭頸部癌症市場,從調查期間的2018年到2023年預計以10.5%的年複合成長率發展。

本報告提供全球頭頸部癌症市場調查,市場概要,市場區隔、各地區的市場趨勢,市場規模的變化與預測,成長要素、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,市場機會,課題分析(DROC)

  • 成長要素
    • 對象疾病的罹患率的上升
    • 全世界的老年人口的增加
    • 政府及民間團體的措施的增加
  • 阻礙因素
    • 使用了數位技術的系統的普及停頓
    • 先進國家市場對醫療設備的課稅
  • 市場機會
  • 主要課題

第7章 全球頭頸部癌症市場:各市場區隔

  • 各診斷成像設備
    • PET(正子放出斷層攝影)
    • CT(電腦斷層診斷設備)
    • MRI(核磁共振成像法)
  • 各內視鏡篩檢設備
    • 喉鏡
    • 喉鏡
    • 內視鏡
  • 各切片檢查篩檢檢查
    • 解剖切片檢查
    • 細微針吸引切片檢查
    • 人類乳突病毒(HPV)檢驗
  • 各牙科診斷法
    • 甲苯胺青染色法
    • 醋酸法
    • 刷子切片檢查
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • 合併及收購分析
  • 協定、合作、聯盟
  • 新產品的銷售

第9章 主要企業的簡介

  • Addent, Inc.
  • GE Healthcare
  • Identafi
  • Philips Healthcare
  • 島津製作所
  • Siemens Healthcare
  • Varian Medical Systems
  • Velscope VX

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 49126

The head and neck cancer diagnostics market is expected to grow at a high rate. Some of the major trends driving the market are the increasing number of cases of target diseases, growing aging population that increased the prevalence of chronic diseases, increasing number of diagnostic procedures for head and neck cancer, and better healthcare initiatives by governments and various private organizations.

The increasing disposable incomes that lead to rise in the healthcare expenditure of people, rising demand for diagnostic imaging, advances in treatment modes, and incorporation of novel technologies in diagnostic equipment will further propel market growth during the forecast period.

Some of the restraining factors for this market includes the low adoption rate of digital technology-based systems, conventional CT and MRI scanners, excise duty imposed on sale of medical devices in mature markets, lack of trained professionals for operating the instruments, high cost associated with the treatment modes and lack of awareness among the people.

Key Market Trends

Diagnostic Imaging Equipment is Expected to Dominate the Market

Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Head and neck cancer is a group of cancers that usually originate in the squamous cells that line the mouth, nose and throat. To confirm a diagnosis of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, panoramic dental x-ray, dental cone beam CT, PET/CT or chest imaging are some of the most common procedures.

Moreover, as per Gunnar Juliusson et al. report published in Acta Radiologica Open Journal 2019, the number of CT examinations per 1000 patients has increased from 51 in 2007 to 108 in 2017 in Europe. However this indicates that the more CT scans are being adopted and hence this is expected to positively impact the diagnostic imaging equipment market as well.

North America is Expected to Dominate the Head and Neck Cancer Diagnostics Market

According to the National Health Institute, the head and neck cancer accounts for approximately 4% of all cancers in the United States. This type of cancer is found to be more than twice as common among men as they are among women. The researchers also estimated that more than 65,000 men and women in the country have been diagnosed with head and neck cancer in 2017. Thus, this huge disease burden will help in the growth of the market.

The Epidemiology and End Results (SEER) Program estimated that 53,000 new cases of oral cavity and pharyngeal cancer occur in the United States in 2019, making up 3% of all new US cancer cases. The SEER Program also estimated that such cancer cases would account for 10,860 US deaths in the year, making up 1.8% of all cancer deaths. Thus, the growth in these programs has helped in the overall growth of the market. In addition, with the rise in the head and neck cancer in the United States, there is an increased demand for diagnostic imaging and new advancements and innovations are seen in the treatment models, which help in the growth of the overall market.

Hence, the increasing geriatric population worldwide, combined with government and private body initiatives are some of the other factors contributing to the growth of the market.

Competitive Landscape

Majority of the head and neck cancer diagnostics equipment are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Incidences of Target Diseases
    • 4.2.2 Rise in Global Geriatric Population Levels
    • 4.2.3 Increasing Number of Diagnostic Procedures for Head and Neck Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Devices and Unfavourable Reimbursement Scenarios
    • 4.3.2 Dearth of Trained Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Diagnostic Method
    • 5.1.1 Diagnostic Imaging Equipment
    • 5.1.2 Endoscopy Screening Equipment
    • 5.1.3 Bioscopy Screening Tests
    • 5.1.4 Dental Diagnostic Methods
    • 5.1.5 Other Diagnostic Methods
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Addent Inc
    • 6.1.2 GE Healthcare
    • 6.1.3 Identafi
    • 6.1.4 Philips Healthcare
    • 6.1.5 Shimadzu Corporation
    • 6.1.6 Siemens Healthineers
    • 6.1.7 Varian Medical Systems
    • 6.1.8 Apteryx Imaging Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS